CVS Health recently announced the resignation of its CEO, Karen Lynch, marking a significant leadership change within the company. Lynch’s departure, occurring in tandem with ongoing challenges faced by CVS Health in managing escalating healthcare costs and plummeting share prices, has drawn considerable attention. David Joyner, previously at the helm of CVS’s Caremark pharmacy benefit...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
